Using FDG-PET to measure early treatment response in head and neck squamous cell carcinoma: quantifying intrinsic variability in order to understand treatment-induced change.

MLA

Hoang, J. K., et al. “Using FDG-PET to Measure Early Treatment Response in Head and Neck Squamous Cell Carcinoma: Quantifying Intrinsic Variability in Order to Understand Treatment-Induced Change.” AJNR. American Journal of Neuroradiology, vol. 34, no. 7, July 2013, pp. 1428–33. EBSCOhost, https://doi.org/10.3174/ajnr.A3412.

APA

Hoang, J. K., Das, S. K., Choudhury, K. R., Yoo, D. S., & Brizel, D. M. (2013). Using FDG-PET to measure early treatment response in head and neck squamous cell carcinoma: quantifying intrinsic variability in order to understand treatment-induced change. AJNR. American Journal of Neuroradiology, 34(7), 1428–1433. https://doi.org/10.3174/ajnr.A3412

Chicago

Hoang, J K, S K Das, K R Choudhury, D S Yoo, and D M Brizel. 2013. “Using FDG-PET to Measure Early Treatment Response in Head and Neck Squamous Cell Carcinoma: Quantifying Intrinsic Variability in Order to Understand Treatment-Induced Change.” AJNR. American Journal of Neuroradiology 34 (7): 1428–33. doi:10.3174/ajnr.A3412.